References
- Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488–92.
- Braakhuis BJ, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005;15:113–20.
- Marcos CÁ, Alonso-Guervós M, Prado NR, Gimeno TS, Iglesias FD, Hermsen M, Genetic model of transformation and neoplastic progression in laryngeal epithelium. Head Neck 2011;33:216–24.
- Rodrigo JP, García-Pedrero JM, Suárez C, Takes RP, Thompson LD, Slootweg PJ, Biomarkers predicting malignant progression of laryngeal epithelial precursor lesion: a systematic review. Eur Arch Otolaryngol 2012;269:1073–83.
- Hermsen M, Alonso Guervós M, Meijer G, van Diest P, Suárez Nieto C, Marcos CA, Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma. Cell Oncol 2005;27:191–8.
- Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 2002;55:98–104.
- Geradts J, Wilson PA. High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol 1996;149:15–20.
- Ali HR, Dawson SJ, Blows FM, Provenzano E, Leung S, Nielsen T, A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer. J Pathol 2012;226:97–107.
- Rodrigo JP, Álvarez-Alija G, Menéndez ST, Mancebo G, Allonca E, García-Carracedo D, Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy. Cancer Prev Res 2011;4:1333–41.
- Hsu PK, Li AF, Wang YC, Hsieh CC, Huang MH, Hsu WH, Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg 2008;135:1029–35.
- Mielcarek-Kuchta D, Olofsson J, Golusinski W. Laminin expression in advanced laryngeal squamous cell carcinoma does not correlate to neck metastases. Eur Arch Otorhinolaryngol 2008;265:1257–61.
- Gale N, Michaels L, Luzar B, Poljak M, Zidar N, Fischinger J, Current review on squamous intraepithelial lesions of the larynx. Histopathology 2009;54:639–56.
- Eversole LR. Dysplasia of the upper aerodigestive tract squamous epithelium. Head Neck Pathol 2009;3:63–8.
- Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 2009;217:516–23.
- Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9–22.
- Nusse R. Wnt signaling in disease and in development. Cell Res 2005;15:28–32.
- Galera-Ruiz H, Ríos-Moreno MJ, González-Cámpora R, Ortega I, Fernández A, García-Escudero A, The cadherin-catenin complex in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2012;269:1183–8.
- Goulioumis AK, Varakis J, Goumas P, Papadaki H. Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma. Eur Arch Otorhinolaryngol 2010;267:1573–8.
- Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53:4477–80.
- Pignataro L, Capaccio P, Pruneri G, Carboni N, Buffa R, Neri A, The predictive value of p53, MDM-2, cyclin D1 and Ki67 in the progression from low-grade dysplasia towards carcinoma of the larynx. J Laryngol Otol 1998;112:455–9.